| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.26T | 1.35T | 1.24T | 1.05T | 990.09B | 889.27B |
| Gross Profit | 511.05B | 531.17B | 495.19B | 370.96B | 368.66B | 356.27B |
| EBITDA | 226.91B | 247.75B | 223.06B | 187.99B | 147.57B | 153.07B |
| Net Income | 133.58B | 140.65B | 129.30B | 101.49B | 90.34B | 92.75B |
Balance Sheet | ||||||
| Total Assets | 1.08T | 1.19T | 1.10T | 971.84B | 926.36B | 862.65B |
| Cash, Cash Equivalents and Short-Term Investments | 320.91B | 433.26B | 388.80B | 321.98B | 280.32B | 279.40B |
| Total Debt | 25.23B | 12.13B | 12.01B | 12.36B | 21.51B | 28.31B |
| Total Liabilities | 280.05B | 329.07B | 309.42B | 272.01B | 274.22B | 278.41B |
| Stockholders Equity | 796.05B | 860.78B | 792.85B | 699.52B | 651.85B | 584.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 128.91B | 153.78B | 64.21B | 70.25B | 101.98B |
| Operating Cash Flow | 0.00 | 164.72B | 187.34B | 88.91B | 95.63B | 121.21B |
| Investing Cash Flow | 0.00 | -41.15B | -62.00B | 10.14B | -40.87B | -27.14B |
| Financing Cash Flow | 0.00 | -82.97B | -77.35B | -75.24B | -59.53B | -25.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥262.27B | 22.16 | ― | 2.18% | 8.08% | -27.93% | |
73 Outperform | ¥2.36T | 16.78 | 15.67% | 1.94% | 8.60% | 10.04% | |
69 Neutral | ¥37.13B | 17.45 | ― | 3.63% | 1.04% | 26.51% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥292.92B | 16.02 | ― | 1.51% | ― | ― | |
60 Neutral | ¥3.71T | 30.49 | 12.54% | 0.48% | 3.70% | -1.69% | |
51 Neutral | ¥48.82B | 17.49 | ― | ― | 6.93% | ― |